Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869817 · ClinicalTrials.gov registry record
Dominantly Inherited Alzheimer Network (DIAN)
A clinical trial of Alzheimers Disease, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 700
- Enrollment target
- 20
- Study locations
NCT00869817: Recruiting study of Alzheimers Disease, sponsored by Washington University School of Medicine.
NCT00869817 is a study of Alzheimers Disease that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 700 participants, below the 3,921-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (82% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869817, a study of Alzheimers Disease, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Conditions Studied
Study Locations (20)
Other
- Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" (FLENI) Instituto de Investigaciones Neurológicas Raúl Correa - Buenos Aires
- Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) - Salta
- Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo
- Grupo Neurociencias de Antioquia - Medellín
- German Center for Neurodegenerative Diseases (DZNE) Munich, and University Hospital Ludwig-Maximilians-Universitat (LMU) Munich - Munich
- German Center for Neurodegenerative Diseases (DZNE) Tübingen and Hertie-Institute for Clinical Brain Research, University of Tübingen - Tübingen
- Niigata University - Niigata
- Osaka City University - Osaka
Florida
- Mayo Clinic Jacksonville - Jacksonville
Indiana
- Indiana University-Indiana Alzheimer Disease Center - Indianapolis
Massachusetts
- Brigham and Women's Hospital - Boston
Missouri
- Washington University in St. Louis School of Medicine - St Louis
New York
- Columbia University - New York
Pennsylvania
- University of Pittsburgh - Pittsburgh
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2009-01 |
| Est. Completion | 2026-07 |
What NCT00869817 shows while recruiting
NCT00869817 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 3,921-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00869817 names 20 study sites across 13 states, led by Other, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT00869817 about?
NCT00869817 is a clinical study titled "Dominantly Inherited Alzheimer Network (DIAN)". The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
What is the current status of trial NCT00869817?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2009-01. Estimated completion is 2026-07.
What conditions does trial NCT00869817 study?
This clinical trial studies the following conditions: Alzheimers Disease.
Who is sponsoring clinical trial NCT00869817?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00869817 being conducted?
This trial has 20 study locations across Florida, Indiana, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00869817's enrollment target sits among peer trials
700 22nd of 147 higher than 126 of 147 other Alzheimers Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimers Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING · Phase 3
-
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
RECRUITING · Phase 2
-
University of Central Florida Music Study
RECRUITING · NA
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING · Phase 3
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia